News

Laurent Pharmaceuticals Receives US$ 3M Development Award From Cystic Fibrosis Foundation Therapeutics

26 July 2016

First Canadian Company To Obtain CFFT Therapeutics Development Award Laurent Pharmaceuticals Inc. (the “Company”), a clinical stage orphan drug company, today announced...

Read More

Laurent Pharmaceuticals featured in Biotech Finances

18 July 2016

Laurent Pharmaceuticals featured in Biotech Finances. Read the article

Read More

EVENTS

Laurent Pharmaceuticals presents data with LAU-7b in Idiopathic Pulmonary Fibrosis at the 2024 ATS International Conference, May 17-22, San Diego, CA, USA
read more
Laurent Pharma to participate to BIO International Convention,  June 3-6 2024, San Diego, CA, USA
read more

Laurent Pharma to participate to BIO International Convention, June 5-8, 2023, Boston, MA

read more
Laurent Pharma to participate to BIO International Convention, June 13-16, 2022 – San Diego, CA
read more
Laurent Pharma to participate to BIO-Europe Spring, March 28-31, 2022
read more